IRA will re­duce out-of-pock­et spend­ing among some Part D en­rollees by $7.4B in 2025, HHS re­port says

Last year
Pharma

Lil­ly re­news Team USA Olympic and Par­a­lympic spon­sor­ship and signs on for Los An­ge­les 2028 Games

Last year
Pharma
Marketing

Boehringer In­gel­heim un­veils lat­est fash­ion in­spired by rare skin dis­ease, cre­at­ed by de­sign stu­dents and men­tors

Last year
Pharma
Marketing

New pro­vi­sion­al, time-lim­it­ed drug ap­proval path­way: House and Sen­ate rein­tro­duce bi­par­ti­san bill

Last year
FDA+
Law

No more FDA ad­comm votes? Re­forms brew as new re­search high­lights de­cline in meet­ings

Last year
FDA+

The $2.7B Pre­ci­sion/Eli Lil­ly deal gets mod­i­fied; Abeona clos­es $25M di­rect of­fer­ing

Last year
News Briefing

Jeff Leerink talks about why he's res­ur­rect­ing Leerink Part­ners af­ter buy­ing his firm back from bank­rupt SVB

Last year
People
Financing

Sum­it­o­mo will lay off 62 New York work­ers af­ter con­sol­i­dat­ing sev­en sub­sidiaries

Last year
People

CDC to re­duce fund­ing for states’ child vac­ci­na­tion pro­grams

Last year
Pharma

Cal­i­for­nia Alzheimer's start­up True­Bind­ing rais­es more than $50M, lays off work­ers twice in June

Last year
People
Financing

No­vo Nordisk files sec­ond round of law­suits against com­pound­ing phar­ma­cies hawk­ing il­le­gal semaglu­tide

Last year
Pharma

Lynn Seely brings ex-My­ovant col­league to Lyel­l's C-suite; Nkar­ta, Zai Lab name new CFOs

Last year
Peer Review

FDA grants full ap­proval to Leqem­bi, open­ing up cov­er­age of Alzheimer’s drug by Medicare

Last year
Pharma
FDA+

Spring­Works stalled in pre-launch mode for brand com­mu­ni­ca­tions af­ter FDA de­ci­sion de­lay

Last year
Pharma
Marketing

As­traZeneca launch­es aware­ness cam­paigns for physi­cians and pa­tients with dual asth­ma mes­sage

Last year
Pharma
Marketing

GAO says FDA's al­lowance of phar­ma­cies to dis­pense abor­tion pill was not sub­ject to con­gres­sion­al re­view

Last year
Pharma
FDA+

Gener­ic in­dus­try group sues Min­neso­ta, call­ing price caps 'un­con­sti­tu­tion­al'

Last year
Pharma
Law

In­dus­try speaks out against ICER's sug­gest­ed up­dates to as­sess­ment frame­work

Last year
Pharma

FDA shifts how it pri­or­i­tizes which phar­ma sites to in­spect

Last year
R&D
Manufacturing

Man­u­fac­tur­ing roundup: Gen­Script to boost pro­duc­tion ca­pac­i­ty; SK Bio­sciences inks MOU for its vac­cine in Thai­land

Last year
Manufacturing

FDA rais­es clean­ing and qual­i­ty con­cerns at an­oth­er Ip­ca Lab­o­ra­to­ries man­u­fac­tur­ing site in In­dia

Last year
Pharma
Manufacturing

No added val­ue for a drug's new in­di­ca­tion? Price should ad­just, re­searchers say

Last year
Pharma

Ther­mo Fish­er to ac­quire da­ta in­tel­li­gence com­pa­ny CorE­vi­tas for $900M+

Last year
Deals
Pharma

Genen­tech yanks Gavre­to's rare thy­roid can­cer in­di­ca­tion, months be­fore hand­ing it back to Blue­print

Last year
Pharma
FDA+
First page Previous page 315316317318319320321 Next page Last page
A service from the Financial Times